BioCina announces opening of new GMP plasmid DNA manufacturing suite

SAN DIEGO and ADELAIDE, Australia, June 13, 2022 /PRNewswire/ — BioCina, a leading contract development and manufacturing organization (CDMO) today announced that the company has expanded its CDMO service offering to include the manufacture of plasmid DNA (pDNA) in a new dedicated GMP…

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *